Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China
· Delayed Price · Currency is CNY 24.35
+0.95 (4.06%)
Apr 29, 2026, 3:00 PM CST
SHA:688393 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 2,278 | 2,217 | 1,620 | 2,336 | 2,053 | 2,844 | Upgrade
|
| Market Cap Growth | -31.74% | 36.86% | -30.68% | 13.78% | -27.80% | -17.60% | Upgrade
|
| Enterprise Value | 1,991 | 1,940 | 1,498 | 2,207 | 1,734 | 2,081 | Upgrade
|
| Last Close Price | 24.35 | 23.69 | 17.25 | 24.66 | 21.60 | 29.54 | Upgrade
|
| PE Ratio | - | - | 76.07 | 58.33 | 48.10 | 35.65 | Upgrade
|
| PS Ratio | 6.48 | 6.44 | 3.44 | 4.70 | 4.05 | 6.48 | Upgrade
|
| PB Ratio | 1.97 | 1.91 | 1.32 | 1.89 | 1.68 | 2.35 | Upgrade
|
| P/TBV Ratio | 2.03 | 1.93 | 1.32 | 1.90 | 1.72 | 2.43 | Upgrade
|
| P/FCF Ratio | - | 131.43 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 131.62 | 55.39 | 457.11 | 136.46 | 211.34 | 47.71 | Upgrade
|
| EV/Sales Ratio | 5.67 | 5.63 | 3.18 | 4.44 | 3.42 | 4.74 | Upgrade
|
| EV/EBITDA Ratio | - | - | 44.48 | 48.25 | 32.22 | 27.63 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 292.63 | 80.72 | 35.40 | Upgrade
|
| EV/FCF Ratio | -320.04 | 115.00 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 2.22 | - | 0.30 | 0.58 | 0.43 | 0.16 | Upgrade
|
| Debt / FCF Ratio | - | 0.18 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.26 | -0.23 | -0.11 | -0.07 | -0.20 | -0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | -268.17 | 19.43 | -4.16 | -2.01 | -4.49 | -8.29 | Upgrade
|
| Net Debt / FCF Ratio | 47.82 | -15.57 | 6.97 | 4.45 | 3.87 | 7.46 | Upgrade
|
| Asset Turnover | 0.27 | 0.26 | 0.34 | 0.36 | 0.37 | 0.33 | Upgrade
|
| Inventory Turnover | 1.33 | 1.44 | 2.00 | 2.35 | 2.88 | 3.01 | Upgrade
|
| Quick Ratio | 7.61 | 5.37 | 4.71 | 3.35 | 4.46 | 7.99 | Upgrade
|
| Current Ratio | 9.43 | 7.34 | 8.19 | 5.14 | 5.21 | 8.51 | Upgrade
|
| Return on Equity (ROE) | -3.39% | -4.25% | 1.21% | 1.71% | 2.41% | 6.33% | Upgrade
|
| Return on Assets (ROA) | -1.96% | -2.57% | -0.21% | 0.34% | 0.97% | 2.77% | Upgrade
|
| Return on Invested Capital (ROIC) | -4.63% | -5.49% | -0.41% | 0.71% | 2.74% | 10.85% | Upgrade
|
| Return on Capital Employed (ROCE) | -3.40% | -4.50% | -0.40% | 0.60% | 1.70% | 4.70% | Upgrade
|
| Earnings Yield | -1.66% | -2.12% | 1.31% | 1.71% | 2.08% | 2.80% | Upgrade
|
| FCF Yield | -0.27% | 0.76% | -1.24% | -0.88% | -3.04% | -2.94% | Upgrade
|
| Dividend Yield | 0.43% | - | 0.58% | 0.61% | 0.65% | 0.91% | Upgrade
|
| Payout Ratio | - | - | 68.14% | 33.62% | 62.34% | 33.00% | Upgrade
|
| Buyback Yield / Dilution | -0.53% | -1.59% | 2.94% | -0.53% | -1.09% | -20.71% | Upgrade
|
| Total Shareholder Return | -0.12% | -1.59% | 3.52% | 0.08% | -0.44% | -19.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.